179 related articles for article (PubMed ID: 16954202)
1. Antibody evolution constrains conformational heterogeneity by tailoring protein dynamics.
Zimmermann J; Oakman EL; Thorpe IF; Shi X; Abbyad P; Brooks CL; Boxer SG; Romesberg FE
Proc Natl Acad Sci U S A; 2006 Sep; 103(37):13722-7. PubMed ID: 16954202
[TBL] [Abstract][Full Text] [Related]
2. Rigidity Emerges during Antibody Evolution in Three Distinct Antibody Systems: Evidence from QSFR Analysis of Fab Fragments.
Li T; Tracka MB; Uddin S; Casas-Finet J; Jacobs DJ; Livesay DR
PLoS Comput Biol; 2015 Jul; 11(7):e1004327. PubMed ID: 26132144
[TBL] [Abstract][Full Text] [Related]
3. Mutational landscape of antibody variable domains reveals a switch modulating the interdomain conformational dynamics and antigen binding.
Koenig P; Lee CV; Walters BT; Janakiraman V; Stinson J; Patapoff TW; Fuh G
Proc Natl Acad Sci U S A; 2017 Jan; 114(4):E486-E495. PubMed ID: 28057863
[TBL] [Abstract][Full Text] [Related]
4. Antibody Structure.
Stanfield RL; Wilson IA
Microbiol Spectr; 2014 Apr; 2(2):. PubMed ID: 26105818
[TBL] [Abstract][Full Text] [Related]
5. Protein dynamics and the immunological evolution of molecular recognition.
Jimenez R; Salazar G; Yin J; Joo T; Romesberg FE
Proc Natl Acad Sci U S A; 2004 Mar; 101(11):3803-8. PubMed ID: 15001706
[TBL] [Abstract][Full Text] [Related]
6. Optimizing recombinant antibody function in SPR immunosensing. The influence of antibody structural format and chip surface chemistry on assay sensitivity.
Townsend S; Finlay WJ; Hearty S; O'Kennedy R
Biosens Bioelectron; 2006 Aug; 22(2):268-74. PubMed ID: 16487701
[TBL] [Abstract][Full Text] [Related]
7. Structural and energetic hot-spots for the interaction between a ladder-like polycyclic ether and the anti-ciguatoxin antibody 10C9Fab.
Ui M; Tanaka Y; Tsumuraya T; Fujii I; Inoue M; Hirama M; Tsumoto K
Mol Biosyst; 2011 Mar; 7(3):793-8. PubMed ID: 21161086
[TBL] [Abstract][Full Text] [Related]
8. Highly covarying residues have a functional role in antibody constant domains.
Proctor EA; Kota P; Demarest SJ; Caravella JA; Dokholyan NV
Proteins; 2013 May; 81(5):884-95. PubMed ID: 23280585
[TBL] [Abstract][Full Text] [Related]
9. Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: a structural insight.
Covaceuszach S; Cattaneo A; Lamba D
Proteins; 2005 Feb; 58(3):717-27. PubMed ID: 15625712
[TBL] [Abstract][Full Text] [Related]
10. ABGEN: a knowledge-based automated approach for antibody structure modeling.
Mandal C; Kingery BD; Anchin JM; Subramaniam S; Linthicum DS
Nat Biotechnol; 1996 Mar; 14(3):323-8. PubMed ID: 9630894
[TBL] [Abstract][Full Text] [Related]
11. An antibody loop replacement design feasibility study and a loop-swapped dimer structure.
Clark LA; Boriack-Sjodin PA; Day E; Eldredge J; Fitch C; Jarpe M; Miller S; Li Y; Simon K; van Vlijmen HW
Protein Eng Des Sel; 2009 Feb; 22(2):93-101. PubMed ID: 19074157
[TBL] [Abstract][Full Text] [Related]
12. Direct observation of adsorption-induced inactivation of antibody fragments surrounded by mixed-PEG layer on a gold surface.
Yoshimoto K; Nishio M; Sugasawa H; Nagasaki Y
J Am Chem Soc; 2010 Jun; 132(23):7982-9. PubMed ID: 20491483
[TBL] [Abstract][Full Text] [Related]
13. Mapping the conformational space accessible to BACE2 using surface mutants and cocrystals with Fab fragments, Fynomers and Xaperones.
Banner DW; Gsell B; Benz J; Bertschinger J; Burger D; Brack S; Cuppuleri S; Debulpaep M; Gast A; Grabulovski D; Hennig M; Hilpert H; Huber W; Kuglstatter A; Kusznir E; Laeremans T; Matile H; Miscenic C; Rufer AC; Schlatter D; Steyaert J; Stihle M; Thoma R; Weber M; Ruf A
Acta Crystallogr D Biol Crystallogr; 2013 Jun; 69(Pt 6):1124-37. PubMed ID: 23695257
[TBL] [Abstract][Full Text] [Related]
14. Engineering antibodies for stability and efficient folding.
Honegger A
Handb Exp Pharmacol; 2008; (181):47-68. PubMed ID: 18071941
[TBL] [Abstract][Full Text] [Related]
15. Comparison of random and oriented immobilisation of antibody fragments on mixed self-assembled monolayers.
Bonroy K; Frederix F; Reekmans G; Dewolf E; De Palma R; Borghs G; Declerck P; Goddeeris B
J Immunol Methods; 2006 May; 312(1-2):167-81. PubMed ID: 16674973
[TBL] [Abstract][Full Text] [Related]
16. A universal combinatorial design of antibody framework to graft distinct CDR sequences: a bioinformatics approach.
Haidar JN; Yuan QA; Zeng L; Snavely M; Luna X; Zhang H; Zhu W; Ludwig DL; Zhu Z
Proteins; 2012 Mar; 80(3):896-912. PubMed ID: 22180101
[TBL] [Abstract][Full Text] [Related]
17. Conformational changes and development of proteinase K resistance in surface-immobilized PrP.
Leclerc E; Vetter S
Arch Virol; 2008; 153(4):683-91. PubMed ID: 18278426
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of human germline antibody 3-23/B3.
Malia TJ; Obmolova G; Almagro JC; Gilliland GL; Teplyakov A
Mol Immunol; 2011 Jul; 48(12-13):1586-8. PubMed ID: 21605907
[TBL] [Abstract][Full Text] [Related]
19. Protein conformational diversity modulates sequence divergence.
Juritz E; Palopoli N; Fornasari MS; Fernandez-Alberti S; Parisi G
Mol Biol Evol; 2013 Jan; 30(1):79-87. PubMed ID: 22396525
[TBL] [Abstract][Full Text] [Related]
20. On the domain pairing in chimeric antibodies.
Teplyakov A; Obmolova G; Carton JM; Gao W; Zhao Y; Gilliland GL
Mol Immunol; 2010 Aug; 47(14):2422-6. PubMed ID: 20554002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
